共 50 条
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation
被引:42
|作者:
Saliba, Walid
[1
,2
,3
]
Rennert, Gad
[1
,2
,4
]
机构:
[1] Technion Israel Inst Technol, Clalit Hlth Serv, Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Haemek Med Ctr, IL-18101 Afula, Israel
[4] Clalit Hlth Serv Headquarters, Off Chief Phys, Dept Epidemiol & Dis Prevent, Tel Aviv, Israel
来源:
关键词:
Atrial fibrillation;
CHA(2)DS(2)-VASc;
Mortality;
Pulmonary embolism;
DEEP VENOUS THROMBOSIS;
VEIN THROMBOSIS;
SERUM 25(OH)D;
THROMBOEMBOLISM;
STROKE;
ATHEROSCLEROSIS;
GUIDELINES;
MANAGEMENT;
POPULATION;
MORTALITY;
D O I:
10.1016/j.amjmed.2013.10.004
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND: The risk stratification score, which includes Congestive heart failure, Hypertension, Age >= 75 [doubled], Diabetes, Stroke [doubled]-Vascular disease, Age 65-74, and Sex category [female] (CHA(2)DS(2)-VASc), is used to predict stroke in atrial fibrillation. However, whether high CHA(2)DS(2)-VASc score carries a higher risk of pulmonary embolism remains unknown. We aimed to investigate the association between the severity of CHA(2)DS(2)-VASc score and the incidence of pulmonary embolism. METHODS: A total of 73,541 adults with atrial fibrillation diagnosed before January 1, 2012, and no history of pulmonary embolism, were retrospectively identified from the computerized database of the Clalit Health Services, which is the largest not-for-profit health maintenance organization in Israel. The CHA(2)DS(2)-VASc score was calculated for each subject at study entry. The cohort was followed for the first occurrence of pulmonary embolism until December 31, 2012 (70,210 person-years). RESULTS: Pulmonary embolism developed in 158 subjects, representing an incidence of 225.0 per 100,000 person-years. The incidence of pulmonary embolism increased with increasing CHA(2)DS(2)-VASc score (P <.001). On Cox proportional analysis, CHA(2)DS(2)-VASc score was significantly associated with pulmonary embolism (hazard ratio, 1.22; 95% confidence interval [CI], 1.13-1.32) for a 1-point increase in CHA(2)DS(2)VASc score. The results were similar after adjusting for anticoagulants and antiplatelet use (hazard ratio, 1.24; 95% CI, 1.14-1.34), and remained unchanged after further adjustment for active malignancy. The predictive values for pulmonary embolism were similar for CHA(2)DS(2)-VASc score and the classic risk stratification score which includes Congestive heart failure, Hypertension, Age > 75 years, Diabetes, and Stroke [doubled] (CHADS(2)); the areas under the receiver operating characteristic curves were 0.619 (95% CI, 0.579-0.660) and 0.616 (95% CI, 0.575-0.656), respectively. CONCLUSIONS: CHA(2)DS(2)-VASc score is directly associated with the incidence of pulmonary embolism in atrial fibrillation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文